SCHEMBL8969411

SCHEMBL8969411

C[Si](C)(C)CCCCOS(C)(=O)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.68
USP2 O75604 2/20 0.68
KDM4E B2RXH2 1/20 0.68
ALDH1A1 P00352 1/20 0.68
LMNA P02545 1/20 0.68
MMP9 P14780 1/20 0.68
ALOX15 P16050 1/20 0.68
CA1 P00915 16/20 0.37
CA2 P00918 16/20 0.37
CA9 Q16790 15/20 0.37
CA12 O43570 5/20 0.36
CA7 P43166 5/20 0.36
CA14 Q9ULX7 5/20 0.36
CA3 P07451 4/20 0.36
CA4 P22748 4/20 0.36
CA6 P23280 4/20 0.36
CA5A P35218 4/20 0.36
CA5B Q9Y2D0 4/20 0.36
RECQL P46063 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10787503 0.98 TSHR (0.65) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL2057502 0.93 USP2 (0.64) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL2058014 0.83 USP2 (0.55) TSHRUSP2KDM4EALDH1A1LMNA
Busulfan SCHEMBL4764696 0.83 TSHR (1.00) TSHRUSP2KDM4EALDH1A1LMNA
Busulfan SCHEMBL4373 0.83 TSHR (1.00) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL4298840 0.80 TSHR (0.94) TSHRUSP2KDM4EALDH1A1LMNA
Busulfan SCHEMBL7195165 0.80 TSHR (0.94) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL8592211 0.80 TSHR (0.94) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL1335477 0.80 TSHR (0.94) TSHRUSP2KDM4EALDH1A1LMNA
SCHEMBL4952202 0.80 TSHR (0.94) TSHRUSP2KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5536732-A REDUCING INFECTIOUSNESS OF HIV MERRELL PHARMACEUTICALS INC. (US) 1996-07-16 US disclosed
EP-0454580-B1 Novel nojirimycin derivatives MERRELL DOW PHARMA (US) 1995-12-27 EP disclosed
US-5252587-A Viricides, aids therapy, antidiabetic agent MERRELL DOW PHARMACEUTICALS, INC. (US) 1993-10-12 US disclosed
EP-0454580-A2 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed
EP-0453692-A1 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed